Present use | Anticipated use | ||
---|---|---|---|
Current users | Non-users | ||
Total | n = 54 | n = 25 | n = 7 |
Abdomena | 54 (100) | 16 (64) | 7 (100) |
Liver disease assessment, n (%) | 48 (89) | 2 (13) | 4 (57) |
Splenomegaly, n (%) | 48 (89) | 2 (13) | 6 (86) |
Pancreas assessment, n (%) | 38 (70) | 4 (25) | 4 (57) |
Cholecystolithiasis, n (%) | 49 (91) | 4 (25) | 7 (100) |
Cholecystitis, n (%) | 46 (85) | 6 (38) | 6 (86) |
Obstructive jaundice, n (%) | 42 (78) | 6 (38) | 4 (57) |
Free fluid in the abdomen, n (%) | 50 (93) | 4 (25) | 7 (100) |
Renal colic, n (%) | 44 (81) | 5 (31) | 5 (71) |
Kidney congestion, n (%) | 50 (93) | 4 (25) | 5 (71) |
Appendicitis, n (%) | 36 (67) | 6 (38) | 3 (43) |
Diverticulitis, n (%) | 30 (56) | 5 (31) | 4 (57) |
Hernia, n (%) | 24 (44) | 6 (38) | 2 (29) |
Abdominal aortic aneurysm, n (%) | 42 (78) | 6 (38) | 5 (71) |
Abdominal trauma, n (%) | 33 (61) | 2 (13) | 5 (71) |
Irritable bowel disease, n (%) | 18 (33) | 4 (25) | 2 (29) |
Bladder diseases, n (%) | 37 (69) | 4 (25) | 5 (71) |
Bladder filling condition, n (%) | 49 (91) | 2 (13) | 7 (100) |
Evaluation of the prostate, n (%) | 40 (74) | 3 (19) | 4 (57) |
Testicular torsion, n (%) | 16 (30) | 4 (25) | 1 (14) |
Testicular pain, n (%) | 24 (44) | 3 (19) | 1 (14) |
Testicular inflammation, n (%) | 20 (37) | 3 (19) | 1 (14) |
Cardiaca | 34 (63) | 11 (44) | 6 (86) |
Pericardial effusion, n (%) | 33 (97) | 4 (36) | 6 (100) |
Evaluation of ventricular size and function, n (%) | 4 (12) | 8 (73) | 1 (17) |
Undifferentiated hypotension, n (%) | 6 (18) | 6 (55) | – |
Valvular assessment, n (%) | 2 (6) | 5 (45) | 1 (17) |
Vasculara | 32 (59) | 13 (52) | 1 (14) |
Deep venous thrombosis, n (%) | 28 (88) | 8 (62) | 1 (100) |
Intima-media thickness / Carotid plaque, n (%) | 17 (53) | 4 (31) | – |
Jugular venous distention, n (%) | 5 (16) | 4 (31) | 1 (100) |
Thoracica | 45 (83) | 15 (60) | 6 (86) |
Pneumothorax, n (%) | 19 (42) | 10 (67) | 3 (50) |
Pleural effusion, n (%) | 42 (93) | 5 (33) | 4 (67) |
Ribs fractures, n (%) | 25 (56) | 10 (67) | 5 (83) |
Chest painORShortness of breathORDyspnea, n (%) | 11 (24) | 5 (33) | 1 (17) |
Auscultatory Changes in the lungs, n (%) | 9 (20) | 7 (47) | 1 (17) |
Chest trauma, n (%) | 14 (31) | 6 (40) | 3 (50) |
Women’s Reproductive Healtha | 14 (26) | 3 (12) | – |
Ovarian pathology, n (%) | 12 (86) | 3 (100) | – |
First term pregnancy, n (%) | 5 (36) | 2 (67) | – |
Ruptured ectopic pregnancy, n (%) | 3 (21) | 2 (67) | – |
Abnormal vaginal Bleeding, n (%) | 6 (43) | 2 (67) | – |
Uterine ultrasoundORuterine mass assessment, n (%) | 11 (79) | 2 (67) | – |
Musculoskeletal & Other conditionsa | 43 (80) | 17 (68) | 3 (43) |
Fracture, n (%) | 12 (28) | 8 (47) | 2 (67) |
Joint effusion, tendon or ligament rupture, n (%) | 21 (49) | 6 (35) | 3 (100) |
Joint assessment and muscular injuries, n (%) | 16 (37) | 5 (29) | – |
Evaluation of rheumatoid arthritis, n (%) | 4 (9) | 3 (18) | 1 (33) |
ThyroidORParathyroid, n (%) | 31 (72) | 9 (53) | 1 (33) |
Adrenal screening, n (%) | 8 (19) | 4 (24) | – |
Evaluation of lymph nodesORPalpable neck mass, n (%) | 33 (77) | 5 (29) | – |
Abscesses and cysts, n (%) | 38 (88) | 4 (24) | 2 (67) |
US for guided procedures, n (%) | 14 (33) | – | – |
US for pain management, n (%) | 4 (9) | – | – |